AI assistant
Sending…
EQUIFAX INC — Director's Dealing 2025
Feb 12, 2025
30136_dirs_2025-02-12_c360672e-b0c2-4f7b-84fd-12ef2297b4d0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: EQUIFAX INC (EFX)
CIK: 0000033185
Period of Report: 2025-02-10
Reporting Person: Mao Cecilia (EVP, Chief Product Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-02-10 | Common Stock | A | 791.0000 | $0.0000 | Acquired | 7501.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-02-10 | Stock Option/Right to Buy | $252.9000 | A | 2541.0000 | Acquired | 2035-02-10 | Common Stock (2541.0000) | Direct |
Footnotes
F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026.
More from EQUIFAX INC
Regulatory Filings
2026
May 13
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 24
Interim / Quarterly Report
2026
Apr 21
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 21
Annual Report
2026
Mar 27
Regulatory Filings
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 26